Summary
Ayala Pharmaceuticals Inc
Founded in 2017
Description
We aim to transform lives Compassion, integrity and efficiency are at the center of everything we do to impact the lives of people living with rare cancers. Our Approach SCROLL OUR PROMISE Science Driven by People We focus on the cure At Ayala, we are ...
Strengths
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Ayala Pharmaceuticals Inc was founded, the company has grown faster than the industry average
Weaknesses
- Ayala Pharmaceuticals Inc has a very small market share in their industry
- Variance of revenue growth is more than the industry average
- Web traffic rankings are worse than the industry average
Annual Revenue
Ayala Pharmaceuticals Inc's annual revenue
$250000
Based on Kona Equity data
-
Revenue per employee
$16666
-
Variance of revenue growth
0.88
-
Annual revenue growth since founding
$35714
-
Revenue growth rate from first known quarter to current
307.9%
Employee Count
15 employees
-
Employee growth rate from first known quarter to current
141.7%
Executives
Joel Kaye
Vice President, Research & Nonclinical Development
j**@ayalapharma.comAdi Mondshine
Lab Manager
a**@ayalapharma.comRoni Mamluk
CEO
r**@ayalapharma.comIrit Klipper
Vice President, Human Resources
i**@ayalapharma.comJeffrey Nieves
Executive Director, Clinical Operations
j**@ayalapharma.comCarmit Nadri-Shay
Vice President, Regulatory Affairs
c**@ayalapharma.comKeren Simhon
Research Associate
k**@ayalapharma.comDavid Caron
Vice President Cmc
d**@ayalapharma.comGary Gordon
Chief Medical Officer
g**@ayalapharma.comShelly Maman
Business Development Manager
s**@ayalapharma.comIbi Tiktin
Manager, Clinical Trial
i**@ayalapharma.comDana Gelbaum
Chief Business Officer
d**@ayalapharma.comOrly Magled
Office Manager
o**@ayalapharma.comJeffery Nieves
Executive Director, Clinical Operations
j**@ayalapharma.comYossi Maimon
Chief Financial Officer
y**@ayalapharma.comNurit Birenboim
Manager, Regulatory Affairs
n**@ayalapharma.comJonathan Yovell
Vice President, Clinical Development
j**@ayalapharma.comAndrea Vergara-Silva
Chief Medical Officer
a**@ayalapharma.comRami Rauch
Director of Bioinformatics
r**@ayalapharma.comAmit Lahav
Director, Quality Assurance
a**@ayalapharma.comPhone Pharmaceuticals
Chief Executive Officer
p**@ayalapharma.comIlana Nachum
Director, Analytics
i**@ayalapharma.comG Score - 4
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Web Analysis
-
Rank
3.64 M
-
Page views per visitor
2.0
-
Daily time
3:06
-
Bounce Rate
89.0 %
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: Ayala Pharmaceuticals Inc
- Category: Pharmaceuticals
- SIC: 28; 283
- NAICS: 32541; 325412
See similar companies
-
By City Wilmington Pharmaceuticals in Wilmington Small Pharmaceuticals in Wilmington Mid-size Pharmaceuticals in Wilmington
-
By State DE Small companies in DE Pharmaceuticals in DE Small Pharmaceuticals in DE Mid-size Pharmaceuticals in DE
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals G Score of 4
-
Firmographic data G Score of 4 Founded in 2017 SIC: 28 SIC: 283 NAICS: 32541 NAICS: 325412 #Drug Manufacturing & Research #Pharmaceuticals #Healthcare #Biotechnology
Frequently Asked Questions
Ayala Pharmaceuticals Inc's headquarters are located at 1313 N. MARKET St. Ste. 5100 Wilmington, DE 19801.
Ayala Pharmaceuticals Inc's official website is ayalapharma.com
Ayala Pharmaceuticals Inc's annual revenue is $250.0 K.
Ayala Pharmaceuticals Inc's SIC: 28; 283
Ayala Pharmaceuticals Inc's NAICS: 32541; 325412.
Ayala Pharmaceuticals Inc has 15 employees
Ayala Pharmaceuticals Inc is in the industry of Pharmaceuticals.